Physician profile
Linda E James
NPI 1023100013
$7,750.14
in general payments reported to CMS, 2019-2025
31 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 93% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $348 · 2021: $320 · 2022: $1,435 · 2023: $1,671 · 2024: $1,548 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,532 · Travel and Lodging: $5.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,532.24 |
| Travel and Lodging | $5.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $2,033.64 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $1,109.98 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $730.01 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $601.19 | 2019-2024 | Jardiance |
| Smith+Nephew, INC. | $551.92 | 2019-2025 | Collagenase Santyl |
| Novo Nordisk INC | $522.06 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $450.68 | 2022-2025 | |
| Organogenesis INC. | $352.45 | 2019-2024 | Cygnus Dual |
| Biotissue Holdings INC. | $267.33 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $194.57 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $141.07 | 2025 | |
| Amgen INC. | $116.38 | 2023-2024 | Repatha, Otezla |
| Pfizer INC. | $109.63 | 2023-2024 | |
| Gilead Sciences, INC. | $99.97 | 2019 | |
| Mimedx Group, INC. | $70.39 | 2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $61.11 | 2023-2024 | |
| Cranial Technologies, INC | $48.70 | 2022-2024 | Doc Band |
| Xeris Pharmaceuticals, INC. | $42.45 | 2025 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.21 | 2022 | |
| Urgo Medical North America, LLC | $22.95 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Exact Sciences Corporation | $22.47 | 2025 | The Cologuard Plus Collection Kit |
| Medtronic, INC. | $21.60 | 2024 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $20.06 | 2019 | |
| Paratek Pharmaceuticals, INC. | $19.66 | 2023 | Nuzyra |
| Shield Therapeutics INC | $18.69 | 2025 | |
| Aroa Biosurgery Incorporated | $18.42 | 2023 | |
| Phadia US INC. | $17.28 | 2021 | |
| Hartmann USA, INC. | $17.13 | 2024 | Zetuvit Plus 10x10 P10 |
| Sanofi Pasteur INC. | $16.20 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.22 | 2019 | |
| Merck Sharp & Dohme LLC | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.